COST-EFFECTIVENESS OF FRACTURE PREVENTION IN ESTABLISHED OSTEOPOROSIS

被引:67
|
作者
JONSSON, B
CHRISTIANSEN, C
JOHNELL, O
HEDBRANDT, J
机构
[1] CTR CLIN & BASIC RES,BALLERUP,DENMARK
[2] MALMO GEN HOSP,DEPT ORTHOPED,S-21401 MALMO,SWEDEN
[3] LINKOPING UNIV,SYST ANAL GRP,LINKOPING,SWEDEN
关键词
COST-EFFECTIVENESS; FRACTURE; MODEL; OSTEOPOROSIS; PREVENTION;
D O I
10.1007/BF01623315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study presents the results of a computer simulation model for calculating the cost-effectiveness and cost-utility of treating patients with established osteoporosis in order to reduce the risk of fractures. The results are based on Swedish data for risk of fracture and costs. The treatment intervention modelled is based on treatment of a 62-year-old woman with established osteoporosis. The cost per hip fracture avoided is 350 000 SEK, assuming a 50% reduction in the risk of fracture due to 5 years of treatment. A sensitivity analysis for changes in the cost and effectiveness of treatment, the risk of fracture and the discount rate is performed. The cost per life-year gained and the cost per quality-adjusted life-year (QALY) gained is presented to enable comparison of the cost-effectiveness of treating osteoporosis with that of other health care interventions. A comparison between treating the same woman for osteoporosis and mild hypertension shows a cost per Life-year gained of 220 000 SEK and 128 000 SEK respectively. Cost per QALY gained is very similar for the two interventions:105 000 SEK and 103 000 SEK respectively. This model provides a tool to enable clinicians, administrators and health policy makers to analyze and understand the economic aspects of a major health policy issue.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 50 条
  • [1] Cost-effectiveness of fracture prevention in established osteoporosis
    Jonsson, B
    Christiansen, C
    Johnell, O
    Hedbrandt, J
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 30 - 38
  • [2] Cost-effectiveness of fracture prevention in established osteoporosis - Discussion
    Haviko, T
    Sorensen
    Lips, P
    Karlsson, G
    Cooper, C
    Tsakalakos, N
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 39 - 40
  • [3] Cost-effectiveness of current treatments for established female osteoporosis
    Stevenson, MD
    Brazier, JE
    Kanis, J
    Lloyd-Jones, M
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S11 - S11
  • [4] Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia
    Mohd-Tahir, Nurul-Ain
    Thomas, Paraidathathu
    Mohamed-Said, Mohd-Shahrir
    Makmor-Bakry, Mohd
    Li, Shu-Chuen
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (03) : 647 - 655
  • [5] Cost-effectiveness of fracture prevention treatments in the elderly
    Fleurence, RL
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2004, 20 (02) : 184 - 191
  • [6] Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis
    Hiligsmann, Mickael
    Vanoverberghe, Marie
    Neuprez, Audrey
    Bruyere, Olivier
    Reginster, Jean-Yves
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (04) : 359 - 366
  • [7] Prevention of osteoporosis: Cost-effectiveness of different pharmaceutical treatments
    AnkjaerJensen, A
    Johnell, O
    OSTEOPOROSIS INTERNATIONAL, 1996, 6 (04) : 265 - 275
  • [9] Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis
    Zethraeus, N
    Ben Sedrine, W
    Caulin, F
    Corcaud, S
    Gathon, HJ
    Haim, M
    Johnell, O
    Jönsson, B
    Kanis, JA
    Tsouderos, Y
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 (11) : 841 - 857
  • [10] Models for Assessing the Cost-Effectiveness of the Treatment and Prevention of Osteoporosis
    N. Zethraeus
    W. Ben Sedrine
    F. Caulin
    S. Corcaud
    H. J. Gathon
    M. Haim
    O. Johnell
    B. Jönsson
    J. A. Kanis
    Y. Tsouderos
    J.-Y. Reginster
    Osteoporosis International, 2002, 13 : 841 - 857